Kelsey Reinhardt

Kelsey Reinhardt

McDermott Will & Schulte

Contact
View Bio
RSS

Latest Posts › Pharmaceutical Industry

Share:

This Week in 340B: May 2023

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

5/11/2023  /  Department of Health and Human Services (HHS) , Drug Pricing , Healthcare , Pharmaceutical Industry , Pharmacies , Prescription Drugs , Section 340B

This Week in 340B: April 2023 #5

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

5/3/2023  /  American Hospital Association et al v Becerra Secretary Of Health And Human Services et al , Covered Entities , Department of Health and Human Services (HHS) , Drug Pricing , Health Care Providers , Medicare , Pharmaceutical Industry , Preliminary Injunctions , Prescription Drugs , Section 340B

This Week in 340B: April 2023 #4

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

4/27/2023  /  Covered Entities , Drug Pricing , Health Care Providers , Healthcare , HRSA , Medicaid , Pharmaceutical Industry , Prescription Drugs , Section 340B

This Week in 340B: April 2023 #3

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

4/18/2023  /  American Hospital Association et al v Becerra Secretary Of Health And Human Services et al , Antitrust Litigation , Covered Entities , Medicare , Pharmaceutical Industry , Pharmacies , Section 340B

This Week in 340B - April 2023 #2

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

4/11/2023  /  Department of Health and Human Services (HHS) , Drug Pricing , Medicare , Pharmaceutical Industry , Pharmacies , Prescription Drugs , Section 340B

This Week in 340B: March 2023 #2

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

3/16/2023  /  Covered Entities , Pharmaceutical Industry , Prescription Drugs , Section 340B

This Week in 340B: February 2023 #3

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

2/28/2023  /  Department of Health and Human Services (HHS) , Drug Pricing , En Banc Review , Manufacturers , Pharmaceutical Industry , Pharmacies , Prescription Drugs , Section 340B

This Week in 340B: February 2023 #2

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

2/22/2023  /  Covered Entities , Drug Pricing , Insurance Litigation , Medicare , Medicare Part B , Pharmaceutical Industry , Prescription Drug Coverage , Reimbursements , Section 340B

This Week in 340B: February 2023

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

2/15/2023  /  Audits , Covered Entities , Healthcare Facilities , HRSA , Medicare , Patients , Pharmaceutical Industry , Prescription Drugs , Section 340B

This Week in 340B: January 2023 #5

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

2/7/2023  /  Antitrust Litigation , Appeals , Covered Entities , Department of Health and Human Services (HHS) , Drug Pricing , Manufacturers , Pharmaceutical Industry , Pharmacies , Prescription Drugs , Section 340B

Genesis Opinion Provides Opportunity for District Court to Determine Definition of “Patient” for 340B Covered Entities

A federal district court likely will determine the 340B program definition of “patient” following a decision by the US Court of Appeals for the Fourth Circuit in Genesis Healthcare v. Becerra. The issue was whether the...more

7/11/2022  /  American Hospital Association et al v Becerra Secretary Of Health And Human Services et al , Appeals , Department of Health and Human Services (HHS) , Dismissals , Genesis HealthCare , HRSA , Pharmaceutical Industry , SCOTUS , Section 340B
86 Results
 / 
View per page
« Previous
Page: of 4

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide